Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121646782 | 12164678 | 2 | F | 20160130 | 20160817 | 20160309 | 20160824 | EXP | US-ASTRAZENECA-2016SE22886 | ASTRAZENECA | 29482.00 | DY | F | Y | 49.00000 | KG | 20160824 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121646782 | 12164678 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | AS NEEDED | U | U | 22056 | ||||||||
| 121646782 | 12164678 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | AS NEEDED | U | U | 22056 | ||||||||
| 121646782 | 12164678 | 3 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | U | U | 0 | 400 | UG | INHALATION POWDER | BID | |||||
| 121646782 | 12164678 | 4 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | U | U | 1147663 | 0 | 400 | UG | INHALATION POWDER | BID | ||||
| 121646782 | 12164678 | 5 | C | PENTASA | MESALAMINE | 1 | 0 | 500 | MG | QID | |||||||||
| 121646782 | 12164678 | 6 | C | METHIMAZEM | 2 | 0 | .5 | DF | TABLET | QD | |||||||||
| 121646782 | 12164678 | 7 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | 20 | MG | QD | |||||||||
| 121646782 | 12164678 | 8 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | 10 | MG | QD | |||||||||
| 121646782 | 12164678 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 UNKNOWN DAILY | 0 | |||||||||||
| 121646782 | 12164678 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121646782 | 12164678 | 1 | Dyspepsia |
| 121646782 | 12164678 | 2 | Dyspepsia |
| 121646782 | 12164678 | 3 | Chronic obstructive pulmonary disease |
| 121646782 | 12164678 | 4 | Chronic obstructive pulmonary disease |
| 121646782 | 12164678 | 5 | Crohn's disease |
| 121646782 | 12164678 | 6 | Thyroid disorder |
| 121646782 | 12164678 | 7 | Arrhythmia |
| 121646782 | 12164678 | 8 | Arrhythmia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121646782 | 12164678 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121646782 | 12164678 | Adverse event | |
| 121646782 | 12164678 | Cough | |
| 121646782 | 12164678 | Crohn's disease | |
| 121646782 | 12164678 | Drug dose omission | |
| 121646782 | 12164678 | Hyperthyroidism | |
| 121646782 | 12164678 | Off label use | |
| 121646782 | 12164678 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121646782 | 12164678 | 1 | 2012 | 0 | ||
| 121646782 | 12164678 | 2 | 2012 | 0 | ||
| 121646782 | 12164678 | 3 | 201512 | 20160130 | 0 | |
| 121646782 | 12164678 | 4 | 20160123 | 0 | ||
| 121646782 | 12164678 | 5 | 201505 | 0 | ||
| 121646782 | 12164678 | 7 | 2005 | 0 | ||
| 121646782 | 12164678 | 8 | 201505 | 0 | ||
| 121646782 | 12164678 | 9 | 2014 | 0 |